Endomet Biosciences, Inc
Publicly observedIrvine, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Irvine | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Endomet Biosciences, Inc | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | GM7JUEEQL4M8 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant10 Apr 2025Publicly observed
NIH SBIR/STTR award: Novel, Non-hormonal Therapeutic for Endometriosis
USD 2,045,762.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
- Grant10 Apr 2025Publicly observed
NIH SBIR/STTR award: Novel, Non-hormonal Therapeutic for Endometriosis
USD 2,045,782.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
- Grant1 Sept 2019Publicly observed
NIH SBIR/STTR award: Novel, Non-hormonal Therapeutic for Endometriosis
USD 177,500.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.